Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrasense S.A. operates as a subsidiary of Guerbet SA.
Metrics to compare | ALINS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALINSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −3.3x | −0.4x | |
PEG Ratio | 0.03 | 0.06 | 0.00 | |
Price/Book | −10.5x | 2.2x | 2.6x | |
Price / LTM Sales | 4.6x | 2.8x | 3.2x | |
Upside (Analyst Target) | - | 83.7% | 50.6% | |
Fair Value Upside | Unlock | 16.7% | 6.6% | Unlock |